Pharmacokinetics of Octreotide in Patients With Cirrhosis and Portal Hypertension; Relationship Between the Plasma Levels of the Analogue and the Magnitude and Duration of the Reduction in Corrected Wedged Hepatic Venous Pressure
release_w3uqnv6sf5ajno3yqufpcma5uu
by
S. A. Jenkins, D. M. Nott, J. N. Baxter
References
NOTE: currently batch computed and may include additional references sources, or be missing recent changes, compared to entity reference list.| Showing 1 - 30 of 31 references (in 89ms) | ||
|---|---|---|
[b0]via fuzzy |
Metabolic Clearance and Plasma Half-Disappearance Time of Exogenous Somatostatin in Man*
MICHAEL SHEPPARD, BRAHM SHAPIRO, BERNARD PIMSTONE, SHIRLEY KRONHEIM, MICHAEL BERELOWITZ, MARTIN GREGORY 1979 Journal of Clinical Endocrinology and Metabolism doi:10.1210/jcem-48-1-50 pmid:422706 | |
[b1]via grobid |
Veber, D. F., Freidinger, R. M., Schwenk-Perlow, R. et al. (1981). A potent cyclic hexapeptide analogue of somatostatin. Nature, 292, 55-58.
| |
[b2]via grobid |
Rosenthal, L. E., Yamashiro, D. J., Rivier, J. et al. (1983).
| |
[b3]via grobid |
Structure-activity relationship of somatoastatin analo- gues in the rabbit ileum and rat colon. J. Clin. Invest., 71, 840-849.
| |
[b4]via grobid |
del Pozo, E., Neufield, M., Schlutr, K. et al. (1986). Endocrine profile of a long acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration. Acta Endocri- nologica, 111, 433-439.
| |
[b5]via grobid |
Kutz, K., Nuesch, E. and Rosenthaler, J. (1986). Pharmacokinetics of SMS 201-995 in healthy subjects.
| |
[b6]via grobid |
Scan J. Gastroenterology, 21 (sup 119), 65-72.
| |
[b7]via grobid |
Erikson, L. S., Brundin, T., Soderlund, C. and Wahren, J. (1987). Haemodynamic effects of a long-standing somatostatin analogue in patients with liver cirrhosis.
| |
[b8]via grobid |
Scand. J. Gastroent., 22, 919-925.
| |
[b9]via grobid |
Tyden, G., Samnegaard, H., Thulin, L. and Friman, L. (1978). Treatment of bleeding oesophageal varices with somatostatin. New Engl. J. Med., 22, 919-925.
| |
[b10]via grobid |
Bories, P., Pomier-Layragues, G., Chotard, J. P., Jacob, C. and Michel, H. (1980). Lasomotostatine dimue l'hypertension portale chez le cirrhotique. Gastroenter- ologie et Biologique, 4, 616-617.
| |
[b11]via grobid |
Bosch, J., Kravetz, D. and Rhodes, J. (1981). Effects of somatostatin on hepatic and systemic haemodynamics in patients with cirrhosis of the liver; comparison with vasopressin. Gastroenterology, 80, 518-525.
| |
[b12]via grobid |
Naeije, R., Hallemans, R., Mois, P., Melot, C. H. and Reding, P. (1982). Effects of vasopressin and somato- statin on haemodynamics and blood gases in patients with liver cirrhosis. Crit. Care Med., 10, 578-582.
| |
[b13]via grobid |
Eriksson, L. S., Law, D., Sato, Y. and Wahren, J. (1984). Influence of somatostatin on splanchnic haemo- dynamics in patients with liver cirrhosis. Clinic Physiol., 4, 5 11.
| |
[b14]via grobid |
Navasa, M., Bosch, J., Chesta, J. et al. (1988). Haemo- dynamics effect of subcutaneous administration of SMS 201-995, a long-acting somatostatin analogue in patients with cirrhosis and portal hypertension.
| |
[b15]via grobid |
J. Hepatol., 64, 123.
| |
[b16]via grobid |
Pringle, S. D., McKee, R. F., Garden, O. J., Lorimer, P. R. and Carter, D. C. (1988). The effects of a long-acting somatostatin analogue on portal and systemic hameo- dynamics in cirrhosis. Alimentary Pharmacol and Ther- apeutics, 2, 451-459.
| |
[b17]via grobid |
Merkel, C., Gatta, A., Zuin, R. et al. (1985). Effect of somatostatin on splanchnic haemodynamics in patients with cirrhosis of the liver and portal hypertension. Digestion, 32, 92-98.
| |
[b18]via grobid |
Sonnenberg, G. E., Keller, U., Perruchoud, A., Bur- khardt, D. and Gyr, K. (1981). Effect of somatostatin on splanchnic haemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology, 80, 526-532.
| |
[b19]via grobid |
Burroughs, A. K., Santana, J. A., Dux, T., Dick R. and McIntyre, N. (1985). Effect of a long-acting analogue of somatostatin (SMS 201-995) on hepatic venous pres- sures and azygos blood flow in cirrhotics. Gastroenter- ology, 26, 562.
| |
[b20]via grobid |
McCormick, P. A., Dick, R., Siringo, S. et al. (1990). Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension. Eur. J. Gastroenterol and Hepatol., 2, 489-492.
| |
[b21]via grobid |
Hanisch, E., Doertenbach, J. and Usadel, K. H. (1992). Somatostatin in acute bleeding oesophageal varices. Pharmacology and Rationale for use. Drugs, 44 (sup 2), 24-35.
| |
[b22]via grobid |
Samnegaard, H., Thulin, L., Andreen, M. et al. (1979). Circulatory effects of somatostatin on anaesthetized dogs. Acta Chir Scand, 145, 209-212.
| |
[b23]via grobid |
Marbach, P., Briner, U., Lemaire, M., Schweitzer, A. and Teraski, T. (1993). From somatostatin to sandosta- tin; pharmacodynamics and pharmacokinetics. Diges- tion, 5 (sup 1), 9-13.
| |
[b24]via grobid |
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I. and Seino, S. (1992). Cloning and functional character- isation of a family of human and mouse somatostatin receptors expressed in brain; gastrointestinal tract and liver. Proc. Natl. Acad. Sci., USA, 78(87), 3930-3934.
| |
[b25]via grobid |
Srikant, C. B. and Patel, Y. C. (1992). Somatostatin receptors. Identification and characterisation in brain membranes. Proct. Natl. Acad. Sci., USA, 78, 1183 1193.
| |
[b26]via grobid |
Miller, C. V., Preston, Sr., Woodhouse, L. F., Farmery, S. M. and Primrose, J. H. (1993). Somatostatin binding in human gastrointestinal tissues: effects of cations and somatostatin analogues. Gut., 34, 1351-1356.
| |
[b27]via grobid |
Marbach, P., Andrew, H., Azria, M. et al. (1988). Chemical structure and pharmacodynamic properties of SMS 201-995 (Sandostatin) in the treatment of acromegaly. In "The Treatment of Acromegaly", Berlin, Springer, 53-60.
| |
[b28]via grobid |
Silvain, C., Carpentier, S., Sautereau, S. et al. (1991). A randomized trial of glypressin plus transdermal nitroglycerin versus octreotide in the control of acute variceal haemorrhage. Hepatology, 14, 1339.
| |
[b29]via grobid |
Jenkins, S. A., Copeland, G., Sutton, R., Kingsnorth, A. N. and Shields, R. (1992). Octreotide (SMS) versus sclerotherapy for variceal bleeding: preliminary re- sults. Br. J. Surg., 79, 1224.
| |
|
| ||